Data Chart will load here...
In 1993, the U.S. Public Health Service convened a panel of 13 non-government scientists and scholars to review the developing field of cost-effectiveness analysis. In 1996 the panel published a book that summarized the state of the field and provided recommendations for the use and conduct of cost-effectiveness analyses in health and medicine (Gold 1996). The book quickly became a standard reference both in the United States and internationally and has been cited more than 6,000 times. The field of cost-effectiveness analysis has advanced significantly in the 17 years since it was published—especially in analytic approaches, quality-of-life assessment, evidence synthesis, modeling, and the reporting of results—and the originally planned update of the work is long overdue. Thus, the time is ripe to update the book, reaffirming concepts that have not changed, modifying those that have, and expanding the report into new areas.

In 2011 a group of leaders in the field began planning for just such an update. Over the next year, and in consultation with members of the Original Panel, the group developed a process and structure for updating the original book. Since October 2012, the Leadership Group—which organizes and facilitates the panel’s work—has had weekly conference calls. Members of the 2nd Panel, who together provide broad expertise in the design and use of cost-effectiveness analyses, were invited during the Fall of 2012 (see the list below).  Everyone who was invited accepted with enthusiasm.  All are volunteering their time to participate in the initiative. 

The Panel is now active, with chapters assigned and chapter outlines completed. Full-panel conference calls have taken place every six weeks since January 2013. Conference calls concerning individual chapters are also ongoing, and interested members of the Original Panel are engaged in the update and have been participating in calls and email correspondence.

The first face-to-face meeting of the Panel is scheduled for October 2013 in conjunction with the annual meetings of the Society for Medical Decision Making. In addition to the efforts of the Panel and the Leadership Group, the Panel’s efforts have in-kind support from the Society for Medical Decision Making, the University of California San Diego (UCSD) Health Services Research Center, and the Duke Clinical Research Institute.  In addition, the Panel has been awarded AHRQ Conference Grant R13-HS022824 to support a second in-person meeting in the spring of 2014 and funding from the Robert Wood Johnson Foundation (Grant 71552) for support of the project, including a roll-out conference. The Panel is applying for funding to support additional meetings.

2nd Panel on Cost-effectiveness in Health and Medicine

Name Title Affiliation
Anirban BasuAssociate Professor in the Departments of Health Services, Pharmacy, and EconomicsUniversity of Washington, Seattle
Dan BrockFrances Glessner Lee Professor of Medical Ethics, Department of Global Health and Social Medicine Harvard University Medical School
David FeenyProfessor, Department of Economics McMaster University, Hamilton, ON Canada
Murray KrahnDirector of THETA (Toronto Health Economics and Technology Assessment Collaborative), the F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, and Professor, Faculties of Medicine and PharmacyUniversity of Toronto
Karen KuntzProfessor, Division of Health Policy and Management University of Minnesota School of Public Health
David MeltzerDirector of the Center for Health and the Social Sciences and Associate Professor, Department of Medicine, Department of Economics, and the Harris School of Public Policy Studies University of Chicago
Peter Neumann*Director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Professor of Medicine Tufts Medical Center
Doug OwensAssociate Director of the Center for Health Care Evaluation at the VA Palo Alto Health Care System and Director of the Center for Health Policy and of the Center for Primary Care and Outcomes Research Stanford University
Lisa Prosser

Associate Professor of Pediatrics and Communicable Diseases
Dept of Pediatrics and Communicable Diseases, University of Michigan Medical School

Associate Professor and Associate Director, Child Health Evaluation and Research (CHEAR) Unit
Dept of Health Management and Policy, University of Michigan School of Public Health

Josh SalomonProfessor of Global Health Harvard University School of Public Health
Gillian Sanders*Associate Professor of Medicine, Division of Clinical Pharmacology, Assistant Professor in Biostatistics and Bioinformatics Duke University
Mark SculpherProfessor of Health Economics at the Centre for Health Economics and Director of the Programme on Economic Evaluation and Health Technology AssessmentUniversity of York, UK
Tom Trikalinos Associate Professor of Health Services, Policy & Practice Brown University

 * Panel Co-chair

Leadership Group

Name Title Affiliation
Theodore Ganiats Professor Emeritus, Health Services Research Center and Department of Family Medicine and Public Health University of California San Diego
Peter Neumann Co-Chair (see above)
Louise Russell Distinguished Professor, Institute for Health and Department of Economics Rutgers University
Gillian Sanders Co-Chair (see above)
Joanna Siegel Senior Research Scientist, Center for Outcomes and Evidence Agency for Healthcare Research and Quality